AHCC01
Find out about the AHCC 01 trial, a completed randomised study comparing tamoxifen with placebo for inoperable liver cancer, with results published in *Hepatology* in 2002.
Trial summary of AHCC 01
AHCC 01 | Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma |
|---|---|
Status | Completed in June 2000 with recruitment of 324 patients. Results published in Hepatology 2002 36:1221-1226. |
Contributing Principal Investigators and Centres | Pierce Chow (SGH, Singapore), Khin Maung Win (Yangon, Myanmar), Phillip Johnson (Shatin, Hong Kong), Soo Khee Chee (NCC, Singapore), Tan Chee Kiat (Singapore), T Manuaba (Denpasar, Indonesia), Thiravud Khuhaprema (Thailand), A Haron (Bangi, Malaysia), Si-Hyun Bae (Korea), J Cebon (Australia), M Findlay (Wellington, New Zealand) |
Protocol Chair | Pierce Chow |